Levofloxacin
Product Images NDC 10544-143

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 10544-143). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 500mg 10ct (Label Levofloxacin Tabs 500mg Bpi(10544 143 10) Macleods(33342 022 08) Rev2)

Levofloxacin Tablets, 500 mg, in a package containing 10 tablets. The label includes storage instructions indicating controlled room temperature and light-resistant storage. It displays the NDC 10544-143-10 and manufacturer code MFG 33342-022-08, with Blenheim Pharmacal, Inc. as the labeler. The label also notes the product is Rx only and includes a barcode and QR code.*

FDA Label Image

750mg 5ct (Label Levofloxacin Tabs 750mg Bpi(10544 906 05) Macleods(33342 023 32) Rev1)

Levofloxacin Tablets, 750mg, packaged as 5 tablets per container. The label displays the NDC 10544-906-05 and manufacturer code MFG 33342-023-32. Labeler is Blenheim Pharmacal, Inc. Instructions include dosage direction to see package insert and storage requirements at controlled room temperature 20°-25°C, with permitted excursions 15°-30°C. The label also advises storing the product in a tight, light-resistant container and keeping it out of reach of children.*

FDA Label Image

Structure (Untitled)

Chemical structure of Levofloxacin shown as a molecular diagram with labeled atoms and bonds, including a fluorine atom and a carboxyl group. The structure includes a piperazine ring and a methyl group, indicating the active ingredient's detailed chemical composition.*

FDA Label Image

Figgraph2 (Untitledgraphlevo2)

A pharmacokinetic curve showing plasma concentration (µg/mL) over time (hours) for Levofloxacin 750 mg administered by oral tablet and intravenous infusion (90 minutes). The graph compares concentration trends between the two administration routes up to 36 hours post-dose.*

FDA Label Image

Figraph3 (Untitledgraphlevo3)

A line graph comparing plasma concentration (µg/mL) of Levofloxacin 500 mg over time (hours) between oral tablet (p.o.) and intravenous (i.v.) administration. The graph shows plasma concentration peaking shortly after administration and declining similarly for both routes up to 36 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.